24 participants
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-22
- Start Date:
- 2026-03-03
- Completion:
- 2028-06-01
Conditions
- Multiple Myeloma (MM)
Interventions
- DRUG
No Results Yet